0001209191-17-020904.txt : 20170315 0001209191-17-020904.hdr.sgml : 20170315 20170315183152 ACCESSION NUMBER: 0001209191-17-020904 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170313 FILED AS OF DATE: 20170315 DATE AS OF CHANGE: 20170315 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Opko Health, Inc. CENTRAL INDEX KEY: 0000944809 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 752402409 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4400 BISCAYNE BLVD. CITY: MIAMI STATE: FL ZIP: 33137 BUSINESS PHONE: 305-575-4138 MAIL ADDRESS: STREET 1: 4400 BISCAYNE BLVD. CITY: MIAMI STATE: FL ZIP: 33137 FORMER COMPANY: FORMER CONFORMED NAME: eXegenics Inc DATE OF NAME CHANGE: 20040505 FORMER COMPANY: FORMER CONFORMED NAME: EXEGENICS INC DATE OF NAME CHANGE: 20011114 FORMER COMPANY: FORMER CONFORMED NAME: CYTOCLONAL PHARMACEUTICS INC /DE DATE OF NAME CHANGE: 19950503 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Logal Adam CENTRAL INDEX KEY: 0001356197 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33528 FILM NUMBER: 17692450 MAIL ADDRESS: STREET 1: OPKO HEALTH, INC. STREET 2: 4400 BISCAYNE BLVD. CITY: MIAMI STATE: FL ZIP: 33137 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-03-13 0 0000944809 Opko Health, Inc. OPK 0001356197 Logal Adam 4400 BISCAYNE BLVD. MIAMI FL 33137 0 1 0 0 Sr. Vice President, CFO Common Stock 2017-03-13 4 M 0 189207 0.56 A 234996 D Common Stock 2017-03-13 4 M 0 75000 2.36 A 309996 D Common Stock 2017-03-13 4 F 0 35728 7.92 D 274268 D Common Stock 2017-03-14 4 S 0 112975 8.0697 D 161293 D Stock Option (Right to Buy) 0.56 2017-03-13 4 M 0 189207 0.00 D 2017-03-15 Common Stock 189207 0 D Stock Option (Right to Buy) 2.36 2017-03-13 4 M 0 75000 0.00 D 2017-04-13 Common Stock 75000 0 D Represents number of shares withheld by the Company at the direction of the reporting person for the payment of exercise price. No shares of Common Stock were sold by the reporting person in connection with this transaction. The reporting person has retained the net number of shares issued upon the exercise of the option (228,479 shares). Closing market price of the Company's common stock on the transaction date. All of the shares reported as disposed of in this Form 4 were sold to pay/satisfy federal and/or state tax withholding in connection with a stock option exercise on March 13, 2017. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.02 to $8.21, inclusive. The reporting person undertakes to provide to OPKO Health, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4. This option became exercisable in forty-eight (48) equal monthly installments until fully vested on March 15, 2011. The options were granted on April 14, 2010 and vested in four equal installments beginning on April 14, 2011. Adam Logal 2017-03-15